Skip to main content

Table 3 Results of the survival analysis for stroke incidence by income level

From: Effect of income level on stroke incidence and the mediated effect of simultaneous diagnosis of metabolic syndrome diseases; a nationwide cohort study in South Korea

 

Total(n)

Stroke incidence (n)

Rate (%)

Adjusted HR model 1 (95% CI)

Adjusted HR model 2 (95% CI)

Adjusted HR model 3 (95% CI)

High income

75,824

1304

1.7

Reference

Reference

Reference

Middle income

67,986

1281

1.9

1.16 (1.07–1.25)

1.15 (1.07–1.25)

1.14 (1.05–1.23)

Low income

57,587

1236

2.1

1.21 (1.12–1.31)

1.19 (1.10–1.29)

1.17 (1.08–1.26)

Medical aid beneficiaries

12,129

768

6.3

1.75 (1.59–1.93)

1.63 (1.48–1.80)

1.61 (1.46–1.78)

Simultaneous diagnosis of two or more MetS diseases

   

–

5.44 (5.10–5.80)

–

Simultaneous diagnosis of three MetS diseases

   

–

–

4.50 (4.21–4.81)

  1. MetS diseases: hypertension, diabetes mellitus, dyslipidemia
  2. Model 1: adjusted for age, sex, residential area, Charlson Comorbidity Index, physical disability severity, diagnosis of ischemic heart disease, and diagnosis of cerebrovascular disease (except stroke)
  3. Model 2: adjusted for age, sex, residential area, Charlson Comorbidity Index, physical disability severity, diagnosis of ischemic heart disease, diagnosis of cerebrovascular disease(except stroke), and simultaneous diagnosis of MetS diseases (≥ 2)
  4. Model 3: adjusted for age, sex, residential area, Charlson Comorbidity Index, physical disability severity, diagnosis of ischemic heart disease, diagnosis of cerebrovascular disease(except stroke), and simultaneous diagnosis of MetS diseases (= 3)
  5. MetS metabolic syndrome, HR hazard ratio, CI confidence interval
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us